Home HOMEPAGE   Fri, 07/19/2019 GMT + 7
    Q & A   Site map Forum   Site map Sitemap   E-mali Contact   Vietnamese Vietnamese
IMPE-QN
Web Sites & Commerce News - Events
Web Sites & Commerce Introduction
Web Sites & Commerce Collaborative activities
Web Sites & Commerce Training
Web Sites & Commerce Specific research studies
Finance & Retail Publications
Published scientific research studies
Journal of Practical Medicine
Monographs of scientific research studies (2001-2006)
Web Sites & Commerce Mass organization activities
Web Sites & Commerce Legal documents
Web Sites & Commerce Statistical data
Web Sites & Commerce Work safety
Web Sites & Commerce Vietnam`s Physicians
Web Sites & Commerce Malariology
Web Sites & Commerce Helminthology
Web Sites & Commerce Other vector-borne diseases

SEARCH

LOGIN
Username
Password

WEBLINKS
Other links

Visiting users: 180
3 7 8 9 2 1 1 6
Online
1 8 0
 Publications Published scientific research studies
Part 1: New and effective antimalarial drugs in global malaria elimination strategies

Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.

St Jean PL, Xue Z, Carter N, Koh GC, Duparc S, Taylor M, Beaumont C, Llanos-Cuentas A, Rueangweerayut R, Krudsood S, Green JA, Rubio JP.Malar J. 2016 Feb 18;15:97. doi: 10.1186/s12936-016-1145-5.PMID: 26888075Free PMC ArticleSimilar articlesSelect item 243603692.

Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.

Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, Arthur P, Chuenchom N, Mhrle JJ, Duparc S, Ugwuegbulam C, Kleim JP, Carter N, Green JA, Kellam L.Lancet. 2014 Mar 22;383(9922):1049-58. doi: 10.1016/S0140-6736(13)62568-4. Epub 2013 Dec 19.PMID: 24360369 Similar articles Select item 154868313.


Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.

Walsh DS, Wilairatana P, Tang DB, Heppner DG Jr, Brewer TG, Krudsood S, Silachamroon U, Phumratanaprapin W, Siriyanonda D, Looareesuwan S.

Clin Infect Dis. 2004 Oct 15;39(8):1095-103. Epub 2004 Sep 24.

PMID: 15486831 Similar articles Select item 270773094.

Primaquine treatment and relapse in Plasmodium vivax malaria.

Rishikesh K, Saravu K.

Pathog Glob Health. 2016;110(1):1-8. doi: 10.1080/20477724.2015.1133033. Epub 2016 Feb 18. Review.

PMID: 27077309 Free PMC ArticleSimilar articles Select item 306503225.

Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.

Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, Saunders DL, Mohammed R, Yilma D, Batista Pereira D, Espino FEJ, Mia RZ, Chuquiyauri R, Val F, Casapa M, Monteiro WM, Brito MAM, Costa MRF, Buathong N, Noedl H, Diro E, Getie S, Wubie KM, Abdissa A, Zeynudin A, Abebe C, Tada MS, Brand F, Beck HP, Angus B, Duparc S, Kleim JP, Kellam LM, Rousell VM, Jones SW, Hardaker E, Mohamed K, Clover DD, Fletcher K, Breton JJ, Ugwuegbulam CO, Green JA, Koh GCKW.

N Engl J Med. 2019 Jan 17;380(3):215-228. doi: 10.1056/NEJMoa1710775.

PMID: 30650322 Free ArticleSimilar articles Select item 279234056.


Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei.

Milner EE, Berman J, Caridha D, Dickson SP, Hickman M, Lee PJ, Marcsisin SR, Read LT, Roncal N, Vesely BA, Xie LH, Zhang J, Zhang P, Li Q.

Malar J. 2016 Dec 7;15(1):588.

PMID: 27923405 Free PMC ArticleSimilar articles Select item 247312387.

Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections.

Li Q, O'Neil M, Xie L, Caridha D, Zeng Q, Zhang J, Pybus B, Hickman M, Melendez V.

Malar J. 2014 Apr 14;13:141. doi: 10.1186/1475-2875-13-141.

PMID: 24731238 Free PMC ArticleSimilar articles Select item 265003518.


Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.

Beck HP, Wampfler R, Carter N, Koh G, Osorio L, Rueangweerayut R, Krudsood S, Lacerda MV, Llanos-Cuentas A, Duparc S, Rubio JP, Green JA.

J Infect Dis. 2016 Mar 1;213(5):794-9. doi: 10.1093/infdis/jiv508.Epub 2015 Oct 23.

PMID: 26500351Free PMC ArticleSimilar articles Select item 274671459.

Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses.

Silvino AC, Costa GL, Arajo FC, Ascher DB, Pires DE, Fontes CJ, Carvalho LH, Brito CF, Sousa TN.

PLoS o­ne. 2016 Jul 28;11(7):e0160172. doi: 10.1371/journal.pone.0160172. eCollection 2016. Erratum in:PLoS o­ne. 2018 Feb 1;13(2):e0192534.

PMID: 27467145 Free PMC ArticleSimilar articles Select item 2624836210.

Exposure-Response Analyses for Tafenoquine after Administration to Patients with Plasmodium vivax Malaria.

Tenero D, Green JA, Goyal N.

Antimicrob Agents Chemother. 2015 Oct;59(10):6188-94. doi: 10.1128/AAC.00718-15. Epub 2015 Jul 27.

PMID: 26248362 Free PMC ArticleSimilar articles Select item 1983583211.

Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.

Yeshiwondim AK, Tekle AH, Dengela DO, Yohannes AM, Teklehaimanot A.

Acta Trop. 2010 Feb;113(2):105-13. doi: 10.1016/j.actatropica.2009.10.001.Epub 2009 Oct 14.

PMID: 19835832 Similar articles Select item 2587006912.

Differential cytochrome P450 2D metabolism alters tafenoquine pharmacokinetics.

Vuong C, Xie LH, Potter BM, Zhang J, Zhang P, Duan D, Nolan CK, Sciotti RJ, Zottig VE, Nanayakkara NP, Tekwani BL, Walker LA, Smith PL, Paris RM, Read LT, Li Q, Pybus BS, Sousa JC, Reichard GA, Smith B, Marcsisin SR.

Antimicrob Agents Chemother. 2015 Jul;59(7):3864-9. doi: 10.1128/AAC.00343-15. Epub 2015 Apr 13.

PMID: 25870069 Free PMC ArticleSimilar articles Select item 2592141613.

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.

Rajapakse S, Rodrigo C, Fernando SD.

Cochrane Database Syst Rev. 2015 Apr 29;(4):CD010458. doi: 10.1002/14651858.CD010458.pub2. Review.

PMID: 25921416 Free PMC ArticleSimilar articles Select item 1736087314.

Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.

Kitchener S, Nasveld P, Edstein MD.

Am J Trop Med Hyg. 2007 Mar;76(3):494-6.

PMID: 17360873 Similar articles Select item 2914171915.

Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial.

Awab GR, Imwong M, Bancone G, Jeeyapant A, Day NPJ, White NJ, Woodrow CJ.

Am J Trop Med Hyg. 2017 Dec;97(6):1782-1787. doi: 10.4269/ajtmh.17-0290. Epub 2017 Oct 26.

PMID: 29141719 Free PMC ArticleSimilar articles Select item 2761891216.

Pathway-specific inhibition of primaquine metabolism by chloroquine/quinine.

Fasinu PS, Tekwani BL, Avula B, Chaurasiya ND, Nanayakkara NP, Wang YH, Khan IA, Walker LA.

Malar J. 2016 Sep 13;15:466. doi: 10.1186/s12936-016-1509-x.

PMID: 2618912 Free PMC ArticleSimilar articles Select item 2939098717.


CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study.

Brasil LW, Rodrigues-Soares F, Santoro AB, Almeida ACG, Khn A, Ramasawmy R, Lacerda MVG, Monteiro WM, Suarez-Kurtz G.

Malar J. 2018 Feb 1;17(1):57. doi: 10.1186/s12936-017-2139-7.

PMID: 29390987 Free PMC ArticleSimilar articles Select item 3026931218.

Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure.

Warrasak S, Euswas A, Fukuda MM, Ittiverakul M, Miller RS, Krudsood S, Ohrt C.

Int Ophthalmol. 2018 Sep 29. doi: 10.1007/s10792-018-1003-2. [Epub ahead of print]

PMID: 30269312 Similar articles Select item 3065032619.

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.

Llanos-Cuentas A, Lacerda MVG, Hien TT, Vlez ID, Namaik-Larp C, Chu CS, Villegas MF, Val F, Monteiro WM, Brito MAM, Costa MRF, Chuquiyauri R, Casapa M, Nguyen CH, Aruachan S, Papwijitsil R, Nosten FH, Bancone G, Angus B, Duparc S, Craig G, Rousell VM, Jones SW, Hardaker E, Clover DD, Kendall L, Mohamed K, Koh GCKW, Wilches VM, Breton JJ, Green JA.

N Engl J Med. 2019 Jan 17;380(3):229-241. doi: 10.1056/NEJMoa1802537.

PMID: 30650326 Free ArticleSimilar articles Select item 2551870920.

Enantioselective metabolism of primaquine by human CYP2D6.

Fasinu PS, Tekwani BL, Nanayakkara NP, Avula B, Herath HM, Wang YH, Adelli VR, Elsohly MA, Khan SI, Khan IA, Pybus BS, Marcsisin SR, Reichard GA, McChesney JD, Walker LA.

Malar J. 2014 Dec 17;13:507. doi: 10.1186/1475-2875-13-507.

PMID: 25518709 Free PMC ArticleSimilar articles

The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.

Peters W, Stewart LB, Robinson BL.

Ann Trop Med Parasitol. 2003 Apr;97(3):221-36.

PMID: 12803854 Similar articles Select item 2935787022.

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.

Baird JK, Battle KE, Howes RE.

Malar J. 2018 Jan 22;17(1):42. doi: 10.1186/s12936-018-2190-z.

PMID: 29357870 Free PMC ArticleSimilar articles

Select item 2912106123.

A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.

Fukuda MM, Krudsood S, Mohamed K, Green JA, Warrasak S, Noedl H, Euswas A, Ittiverakul M, Buathong N, Sriwichai S, Miller RS, Ohrt C.

PLoS o­ne. 2017 Nov 9;12(11):e0187376. doi: 10.1371/journal.pone.0187376. eCollection 2017.

PMID: 29121061 Free PMC ArticleSimilar articles Select item 2665410124.

Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.

Nelwan EJ, Ekawati LL, Tjahjono B, Setiabudy R, Sutanto I, Chand K, Ekasari T, Djoko D, Basri H, Taylor WR, Duparc S, Subekti D, Elyazar I, Noviyanti R, Sudoyo H, Baird JK.

BMC Med. 2015 Dec 11;13:294. doi: 10.1186/s129 16-015-0535-9.

PMID: 26654101 Free PMC ArticleSimilar articles Select item 2085016125.

Efficacy and safety of chloroquine for treatment in patients with uncomplicated Plasmodium vivax infections in endemic countries.

Naing C, Aung K, Win DK, Wah MJ.

Trans R Soc Trop Med Hyg. 2010 Nov;104(11):695-705. doi: 10.1016/j.trstmh.2010.08.009.Epub 2010 Sep 20. Review.

PMID: 20850161 Similar articles Select item 2438689126.

Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds.

Marcsisin SR, Sousa JC, Reichard GA, Caridha D, Zeng Q, Roncal N, McNulty R, Careagabarja J, Sciotti RJ, Bennett JW, Zottig VE, Deye G, Li Q, Read L, Hickman M, Dhammika Nanayakkara NP, Walker LA, Smith B, Melendez V, Pybus BS.

Malar J. 2014 Jan 3;13:2. doi: 10.1186/1475-2875-13-2.

PMID: 24386891Free PMC ArticleSimilar articles Select item 2967719927.

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.

Watson J, Taylor WRJ, Bancone G, Chu CS, Jittamala P, White NJ.

PLoS Negl Trop Dis. 2018 Apr 20;12(4):e0006440. doi: 10.1371/journal.pntd.0006440. eCollection 2018 Apr.

PMID: 29677199 Free PMC ArticleSimilar articles Select item 1868273928.

A randomised trial of an eight-week, o­nce weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, Pakistan.

Leslie T, Mayan I, Mohammed N, Erasmus P, Kolaczinski J, Whitty CJ, Rowland M.

PLoS o­ne. 2008 Aug 6;3(8):e2861. doi: 10.1371/journal.pone.0002861.

PMID: 18682739 Free PMC ArticleSimilar articles Select item 2421556529.

Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China.

Liu H, Yang HL, Xu JW, Wang JZ, Nie RH, Li CF.

Malar J. 2013 Nov 11;12:409. doi: 10.1186/1475-2875-12-409.

PMID: 24215565 Free PMC ArticleSimilar articles Select item 2650575330.

Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: A randomised placebo-controlled trial and mathematical model.

Robinson LJ, Wampfler R, Betuela I, Karl S, White MT, Li Wai Suen CS, Hofmann NE, Kinboro B, Waltmann A, Brewster J, Lorry L, Tarongka N, Samol L, Silkey M, Bassat Q, Siba PM, Schofield L, Felger I, Mueller I.

PLoS Med. 2015 Oct 27;12(10):e1001891. doi: 10.1371/journal.pmed.1001891. eCollection 2015 Oct.

PMID: 26505753 Free PMC ArticleSimilar articles Select item 2852605631.

The blood schizonticidal activity of tafenoquine makes an essential contribution to its prophylactic efficacy in nonimmune subjects at the intended dose (200 mg).

Dow G, Smith B.

Malar J. 2017 May 19;16(1):209. doi: 10.1186/s12936-017-1862-4. Review.

PMID: 28526056 Free PMC ArticleSimilar articles Select item 2366923232.

Blood stage of Plasmodium vivax in central China is still susceptible to chloroquine plus primaquine combination therapy.

Zhu G, Lu F, Cao J, Zhou H, Liu Y, Han ET, Gao Q.

Am J Trop Med Hyg. 2013 Jul;89(1):184-7. doi: 10.4269/ajtmh.12-0683. Epub 2013 May 13.

PMID: 23669232 Free PMC ArticleSimilar articles Select item 2215206533.

Primaquine in vivax malaria: an update and review o­n management issues.

Fernando D, Rodrigo C, Rajapakse S.

Malar J. 2011 Dec 12;10:351. doi: 10.1186/1475-2875-10-351. Review.

PMID: 22152065 Free PMC ArticleSimilar articles Select item 3064612934.

Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.

Baird JK, Louisa M, Noviyanti R, Ekawati L, Elyazar I, Subekti D, Chand K, Gayatri A, Instiaty, Soebianto S, Crenna-Darusallam C, Djoko D, Hasto BD, Meriyenes D, Wesche D, Nelwan EJ, Sutanto I, Sudoyo H, Setiabudy R.

JAMA Netw Open. 2018 Aug 3;1(4):e181449. doi: 10.1001/jamanetworkopen.2018.1449.

PMID: 30646129 Free PMC ArticleSimilar articles Select item 1047915935.

Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.

Walsh DS, Looareesuwan S, Wilairatana P, Heppner DG Jr, Tang DB, Brewer TG, Chokejindachai W, Viriyavejakul P, Kyle DE, Milhous WK, Schuster BG, Horton J, Braitman DJ, Brueckner RP.

J Infect Dis. 1999 Oct;180(4):1282-7.

PMID: 10479159 Similar articles Select item 2752880036.

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.

Ebstie YA, Abay SM, Tadesse WT, Ejigu DA.

Drug Des Devel Ther. 2016 Jul 26;10:2387-99. doi: 10.2147/DDDT.S61443. eCollection 2016. Review.

PMID: 27528800 Free PMC ArticleSimilar articles Select item 1703868037.


Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.

Alvarez G, Pieros JG, Tobn A, Ros A, Maestre A, Blair S, Carmona-Fonseca J.

Am J Trop Med Hyg. 2006 Oct;75(4):605-9.Erratum in: Am J Trop Med Hyg. 2006 Dec;75(6):1238.

PMID: 17038680 Similar articles Select item 2326299738.

In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.

Ganguly S, Saha P, Guha SK, Das S, Bera DK, Biswas A, Kundu PK, Saha B, Ray K, Maji AK.

Antimicrob Agents Chemother. 2013 Mar;57(3):1246-51. doi: 10.1128/AAC.02050-12. Epub 2012 Dec 21.

PMID: 23262997 Free PMC ArticleSimilar articles Select item 2378289839.

The metabolism of primaquine to its active metabolite is dependent o­n CYP 2D6.

Pybus BS, Marcsisin SR, Jin X, Deye G, Sousa JC, Li Q, Caridha D, Zeng Q, Reichard GA, Ockenhouse C, Bennett J, Walker LA, Ohrt C, Melendez V.

Malar J. 2013 Jun 20;12:212. doi: 10.1186/1475-2875-12-212.

PMID: 23782898 Free PMC ArticleSimilar articles Select item 3017689740.

A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.

Saravu K, Tellapragada C, Kulavalli S, Xavier W, Umakanth S, Brahmarouphu G, Srinivas NK, Channabasavaiah JP, Bava A, Saadi AV, Guddattu V, Satyamoorthy K, Bhat K.

Malar J. 2018 Sep 3;17(1):321. doi: 10.1186/s12936-018-2472-5.

PMID: 30176897 Free PMC ArticleSimilar articles

[Plasmodium vivax malaria: treatment of primary attacks with primaquine, in three different doses, and a fixed dose of chloroquine, Antioquia, Colombia, 2003-2004].

Carmona-Fonseca J, Alvarez G.

Biomedica. 2006 Sep;26(3):353-65. Spanish.

PMID: 17175999 Similar articles Select item 2230343742.

Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SP.

Kolaczinski K, Leslie T, Ali I, Durrani N, Lee S, Barends M, Beshir K, Ord R, Hallett R, Rowland M.

PLoS o­ne. 2012;7(1):e28957. doi: 10.1371/journal.pone.0028957. Epub 2012 Jan 31.

PMID: 22303437 Free PMC ArticleSimilar articles Select item 2132416143.

Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.

Muhamad P, Ruengweerayut R, Chacharoenkul W, Rungsihirunrat K, Na-Bangchang K.

Malar J. 2011 Feb 16;10:44. doi: 10.1186/1475-2875-10-44.

PMID: 21324161 Free PMC ArticleSimilar articles Select item 1796791744.


Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.

Karunajeewa HA, Ilett KF, Mueller I, Siba P, Law I, Page-Sharp M, Lin E, Lammey J, Batty KT, Davis TM.

Antimicrob Agents Chemother. 2008 Jan;52(1):237-43. Epub 2007 Oct 29.

PMID:17967917 Free PMC ArticleSimilar articles Select item 2309029845.

[Plasmodium vivax malaria recurrence according to the use of primaquine: analysis of longitudinal descriptive studies].

Carmona-Fonseca J.

Rev Bras Epidemiol.2012 Sep;15(3):488-503. Review. Spanish.

PMID: 23090298 Free ArticleSimilar articles Select item 2513363046.

Evaluation of antimalarial activity and toxicity of a new primaquine prodrug.

Davano MG, Aguiar AC, Dos Santos LA, Padilha EC, Campos ML, de Andrade CR, da Fonseca LM, Dos Santos JL, Chin CM, Krettli AU, Peccinini RG.

PLoS o­ne. 2014 Aug 18;9(8):e105217. doi: 10.1371/journal.pone.0105217. eCollection 2014.

PMID: 25133630 Free PMC ArticleSimilar articles Select item 1854128047.

The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.

Elmes NJ, Nasveld PE, Kitchener SJ, Kocisko DA, Edstein MD.

Trans R Soc Trop Med Hyg. 2008 Nov;102(11):1095-101. doi: 10.1016/j.trstmh.2008.04.024.Epub 2008 Jun 9.

PMID: 18541280 Similar articles Select item 2285654948.

CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine.

Pybus BS, Sousa JC, Jin X, Ferguson JA, Christian RE, Barnhart R, Vuong C, Sciotti RJ, Reichard GA, Kozar MP, Walker LA, Ohrt C, Melendez V.

Malar J. 2012 Aug 2;11:259. doi: 10.1186/1475-2875-11-259.

PMID: 22856549 Free PMC ArticleSimilar articles Select item 2564585649.

Differential CYP 2D6 metabolism alters primaquine pharmacokinetics.

Potter BM, Xie LH, Vuong C, Zhang J, Zhang P, Duan D, Luong TL, Bandara Herath HM, Dhammika Nanayakkara NP, Tekwani BL, Walker LA, Nolan CK, Sciotti RJ, Zottig VE, Smith PL, Paris RM, Read LT, Li Q, Pybus BS, Sousa JC, Reichard GA, Marcsisin SR.

Antimicrob Agents Chemother. 2015 Apr;59(4):2380-7. doi: 10.1128/AAC.00015-15. Epub 2015 Feb 2.

PMID: 25645856 Free PMC ArticleSimilar articles Select item 2371870550.

Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapse.

Macareo L, Lwin KM, Cheah PY, Yuentrakul P, Miller RS, Nosten F.

Malar J. 2013 May 29;12:173. doi: 10.1186/1475-2875-12-173.

PMID: 23718705 Free PMC ArticleSimilar articles Select item 3010375151.

Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry.

Avula B, Tekwani BL, Chaurasiya ND, Fasinu P, Dhammika Nanayakkara NP, Bhandara Herath HMT, Wang YH, Bae JY, Khan SI, Elsohly MA, McChesney JD, Zimmerman PA, Khan IA, Walker LA.

Malar J. 2018 Aug 13;17(1):294. doi: 10.1186/s12936-018-2433-z.

PMID: 30103751 Free PMC ArticleSimilar articles Select item 894097452.

Short report: primaquine-tolerant Plasmodium vivax in an Italian traveler from Guatemala.

Signorini L, Matteelli A, Castelnuovo F, Castelli F, Oladeji O, Carosi G.

Am J Trop Med Hyg. 1996 Nov;55(5):472-3.

PMID: 8940974 Similar articles Select item 1158465753.

Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.

Edstein MD, Walsh DS, Eamsila C, Sasiprapha T, Nasveld PE, Kitchener S, Rieckmann KH.

Med Trop (Mars). 2001;61(1):56-8. Review.

PMID: 11584657 Similar articles Select item 2684819954.

Therapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax: A systematic review and meta-analysis.

Zuluaga-Idarraga LM, Tamayo Perez ME, Aguirre-Acevedo DC.

Colomb Med (Cali). 2015 Dec 30;46(4):183-91. Review.

PMID: 26848199 Free PMC ArticleSimilar articles Select item 2549560755.

The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea.

Ingram RJ, Crenna-Darusallam C, Soebianto S, Noviyanti R, Baird JK.

Malar J. 2014 Dec 12;13:488. doi: 10.1186/1475-2875-13-488.

PMID: 25495607 Free PMC ArticleSimilar articles Select item 2468201856.

Validation of a method for the simultaneous quantification of chloroquine, desethylchloroquine and primaquine in plasma by HPLC-DAD.

Zuluaga-Idrraga L, Yepes-Jimnez N, Lpez-Crdoba C, Blair-Trujillo S.

J Pharm Biomed Anal. 2014 Jul;95:200-6. doi: 10.1016/j.jpba.2014.03.006. Epub 2014 Mar 12.

PMID: 24682018 Similar articles Select item 912583157.

Studies o­n Plasmodium vivax relapse pattern in Kheda district, Gujarat.

Srivastava HC, Sharma SK, Bhatt RM, Sharma VP.

Indian J Malariol. 1996 Dec;33(4):173-9.

PMID: 9125831 Similar articles Select item 2612670858.

Resistance of infection by Plasmodium vivax to chloroquine in Bolivia.

Aez A, Moscoso M, Laguna , Garnica C, Melgar V, Cuba M, Gutierrez S, Ascaso C.

Malar J. 2015 Jul 1;14:261. doi: 10.1186/s12936-015-0774-4.

PMID: 26126708 Free PMC ArticleSimilar articles Select item 1502492759.

Compliance with 14-day primaquine therapy for radical cure of vivax malaria--a randomized placebo-controlled trial comparing unsupervised with supervised treatment.

Leslie T, Rab MA, Ahmadzai H, Durrani N, Fayaz M, Kolaczinski J, Rowland M.

Trans R Soc Trop Med Hyg. 2004 Mar;98(3):168-73.

PMID: 15024927 Similar articles Select item 2526766660.

Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).

Saunders D, Vanachayangkul P, Imerbsin R, Khemawoot P, Siripokasupkul R, Tekwani BL, Sampath A, Nanayakkara NP, Ohrt C, Lanteri C, Gettyacamin M, Teja-Isavadharm P, Walker L.

Antimicrob Agents Chemother. 2014 Dec;58(12):7283-91. doi: 10.1128/AAC.02576-13. Epub 2014 Sep 29.

PMID: 25267666 Free PMC ArticleSimilar articles

PFMDR1 polymorphisms influence o­n in vitro sensitivity of thai plasmodium falciparum isolates to primaquine, sitamaquine and tafenoquine.

Kaewpruk N, Tan-ariya P, Ward SA, Sitthichot N, Suwandittakul N, Mungthin M.

Southeast Asian J Trop Med Public Health. 2016 May;47(3):366-76.

PMID:27405118 Similar articles Select item 1067409862.

Treatment of vivax malaria o­n the western border of Thailand.

Luxemburger C, van Vugt M, Jonathan S, McGready R, Looareesuwan S, White NJ, Nosten F.

Trans R Soc Trop Med Hyg. 1999 Jul-Aug;93(4):433-8.

PMID: 10674098 Similar articles Select item 1537843863.

Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.

Walsh DS, Eamsila C, Sasiprapha T, Sangkharomya S, Khaewsathien P, Supakalin P, Tang DB, Jarasrumgsichol P, Cherdchu C, Edstein MD, Rieckmann KH, Brewer TG.

J Infect Dis. 2004 Oct 15;190(8):1456-63. Epub 2004 Sep 20.

PMID: 15378438 Similar articles Select item 2104054564.

Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria o­n the Thai-Myanmar border.

Takeuchi R, Lawpoolsri S, Imwong M, Kobayashi J, Kaewkungwal J, Pukrittayakamee S, Puangsa-art S, Thanyavanich N, Maneeboonyang W, Day NP, Singhasivanon P.

Malar J. 2010 Nov 1;9:308. doi: 10.1186/1475-2875-9-308.

PMID: 21040545 Free PMC ArticleSimilar articles Select item 1798435965.

Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.

Marfurt J, Meller I, Sie A, Maku P, Goroti M, Reeder JC, Beck HP, Genton B.

Am J Trop Med Hyg. 2007 Nov;77(5):947-54.

PMID: 17984359 Similar articles Select item 1555025466.

Treatment of acute vivax malaria with tafenoquine.

Nasveld P, Kitchener S.

Trans R Soc Trop Med Hyg. 2005 Jan;99(1):2-5.

PMID: 15550254 Similar articles Select item 1121409367.

In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine.

Villalobos-Salcedo JM, Tada MS, Kimura E, Menezes MJ, Pereira da Silva LH.

Ann Trop Med Parasitol. 2000 Dec;94(8):749-58.

PMID: 11214093 Similar articles Select item 2272711368.

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study.

Townell N, Looke D, McDougall D, McCarthy JS.

Malar J. 2012 Jun 22;11:214. doi: 10.1186/1475-2875-11-214.

PMID: 22727113 Free PMC ArticleSimilar articles Select item 2266559669.

Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances.

Deye GA, Gettayacamin M, Hansukjariya P, Im-erbsin R, Sattabongkot J, Rothstein Y, Macareo L, Fracisco S, Bennett K, Magill AJ, Ohrt C.

Am J Trop Med Hyg. 2012 Jun;86(6):931-5. doi: 10.4269/ajtmh.2012.11-0552.

PMID: 22665596 Free PMC ArticleSimilar articles Select item 1243515870.

Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.

Yadav RS, Ghosh SK.

J Parasitol. 2002 Oct;88(5):1042-4.

PMID: 12435158 Similar articles Select item 1037963271.

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences.

Tamminga WJ, Wemer J, Oosterhuis B, Weiling J, Wilffert B, de Leij LF, de Zeeuw RA, Jonkman JH.

Eur J Clin Pharmacol. 1999 May;55(3):177-84.

PMID: 10379632 Similar articles Select item 1262515072.

Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria in Australian Defence Force personnel.

Nasveld P, Kitchener S, Edstein M, Rieckmann K.

Trans R Soc Trop Med Hyg. 2002 Nov-Dec;96(6):683-4.

PMID: 12625150 Similar articles Select item 3078299173.

Monitoring the Efficacy of Chloroquine-Primaquine Therapy for UncomplicatedPlasmodium vivaxMalaria in the Main Transmission Hotspot of Brazil.

Ladeia-Andrade S, Menezes MJ, de Sousa TN, Silvino ACR, de Carvalho JF Jr, Salla LC, Nery OA, de Melo GNP, Corder RM, Rodrigues PT, Ferreira MU.

Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.01965-18. doi: 10.1128/AAC.01965-18. [Epub ahead of print]

PMID: 30782991 Similar articles Select item 1793358574.

Neglect of Plasmodium vivax malaria.

Baird JK.

Trends Parasitol. 2007 Nov;23(11):533-9. Epub 2007 Oct 22. Review.

PMID: 17933585 Similar articles Select item 2229727975.

In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010.

Congpuon K, Satimai W, Sujariyakul A, Intanakom S, Harnpitakpong W, Pranuth Y, Cholpol S, Bualombai P.

J Vector Borne Dis. 2011 Dec;48(4):190-6.

PMID: 22297279 Free ArticleSimilar articles Select item 2855871276.

Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes.

Maneerattanasak S, Gosi P, Krudsood S, Chimma P, Tongshoob J, Mahakunkijcharoen Y, Sukasem C, Imwong M, Snounou G, Khusmith S.

Malar J. 2017 May 30;16(1):228. doi: 10.1186/s12936-017-1877-x.

PMID: 28558712Free PMC ArticleSimilar articlesSelect item 2450267977.

A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.

Dow GS, McCarthy WF, Reid M, Smith B, Tang D, Shanks GD.

Malar J. 2014 Feb 6;13:49. doi: 10.1186/1475-2875-13-49.

PMID: 24502679Free PMC ArticleSimilar articlesSelect item 2408811378.

Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.

Bennett JW, Pybus BS, Yadava A, Tosh D, Sousa JC, McCarthy WF, Deye G, Melendez V, Ockenhouse CF.

N Engl J Med. 2013 Oct 3;369(14):1381-2. doi: 10.1056/NEJMc1301936. No abstract available.

PMID: 24088113Free ArticleSimilar articlesSelect item 1919021179.

Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment.

Carmona-Fonseca J, Alvarez G, Maestre A.

Am J Trop Med Hyg. 2009 Feb;80(2):188-93.

PMID: 19190211Similar articlesSelect item 1696905980.

Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in Thailand.

Krudsood S, Wilairatana P, Tangpukdee N, Chalermrut K, Srivilairit S, Thanachartwet V, Muangnoicharoen S, Luplertlop N, Brittenham GM, Looareesuwan S.

Korean J Parasitol. 2006 Sep;44(3):221-8.

PMID:16969059Free PMC ArticleSimilar articles

Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.

Vijaykadga S, Rojanawatsirivej C, Congpoung K, Wilairatana P, Satimai W, Uaekowitchai C, Pumborplub B, Sittimongkol S, Pinyorattanachote A, Prigchoo P.

Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):566-9.

PMID: 15689067Similar articlesSelect item 1056282382.

Chloroquine sensitivity of Plasmodium vivax in Thailand.

Looareesuwan S, Wilairatana P, Krudsood S, Treeprasertsuk S, Singhasivanon P, Bussaratid V, Chokjindachai W, Viriyavejakul P, Chalermrut K, Walsh D S, White J.

Ann Trop Med Parasitol. 1999 Apr;93(3):225-30.

PMID: 10562823Similar articlesSelect item 2710904083.

Therapeutic failure of primaquine and need for new medicines in radical cure of Plasmodium vivax.

Thomas D, Tazerouni H, Sundararaj KG, Cooper JC.

Acta Trop. 2016 Aug;160:35-8. doi: 10.1016/j.actatropica.2016.04.009.Epub 2016 Apr 21. Review.

PMID: 27109040Similar articlesSelect item 1757097384.

Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.

Krudsood S, Tangpukdee N, Muangnoicharoen S, Thanachartwet V, Luplertlop N, Srivilairit S, Wilairatana P, Kano S, Ringwald P, Looareesuwan S.

Korean J Parasitol. 2007 Jun;45(2):111-4.

PMID: 17570973Free PMC ArticleSimilar articlesSelect item 2565102085.

Primaquine and relapses of Plasmodium vivax. Meta analysis of controlled clinical trials.

Carmona Fonseca J.

Rev Bras Epidemiol. 2015 Jan-Mar;18(1):174-93. doi: 10.1590/1980-5497201500010014. Epub 2015 Mar 1. English, Spanish.

PMID: 25651020Free ArticleSimilar articlesSelect item 1208885286.

Sensitivity of Plasmodium vivax to chloroquine in Sa Kaeo Province, Thailand.

Congpuong K, Na-Bangchang K, Thimasarn K, Tasanor U, Wernsdorfer WH.

Acta Trop. 2002 Aug;83(2):117-21.

PMID: 12088852Similar articlesSelect item 909342487.

Halofantrine and primaquine for radical cure of malaria in Irian Jaya, Indonesia.

Fryauff DJ, Baird JK, Basri H, Wiady I, Purnomo, Bangs MJ, Subianto B, Harjosuwarno S, Tjitra E, Richie TL, Hoffman SL.

Ann Trop Med Parasitol. 1997 Jan;91(1):7-16.

PMID: 9093424Similar articlesSelect item 1071775488.

Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand.

Looareesuwan S, Wilairatana P, Glanarongran R, Indravijit KA, Supeeranontha L, Chinnapha S, Scott TR, Chulay JD.

Trans R Soc Trop Med Hyg. 1999 Nov-Dec;93(6):637-40.

PMID: 10717754Similar articlesSelect item 2370120289.

Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects.

Miller AK, Harrell E, Ye L, Baptiste-Brown S, Kleim JP, Ohrt C, Duparc S, Mhrle JJ, Webster A, Stinnett S, Hughes A, Griffith S, Beelen AP.

Br J Clin Pharmacol. 2013 Dec;76(6):858-67. doi: 10.1111/bcp.12160.

PMID: 23701202Free PMC ArticleSimilar articlesSelect item 2478007090.

Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.

DiTusa C, Kozar MP, Pybus B, Sousa J, Berman J, Gettayacamin M, Im-erbsin R, Tungtaeng A, Ohrt C.

J Parasitol. 2014 Oct;100(5):671-3. doi: 10.1645/13-480.1. Epub 2014 Apr 29.

PMID: 24780070Similar articlesSelect item 1568906891.

Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.

Hamedi Y, Safa O, Zare S, Tan-ariya P, Kojima S, Looareesuwan S.

Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):570-4.

PMID: 15689068Similar articlesSelect item 3044214392.

Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study.

Puaprasert K, Chu C, Saralamba N, Day NPJ, Nosten F, White NJ, Dondorp AM, Imwong M.

Malar J. 2018 Nov 15;17(1):427. doi: 10.1186/s12936-018-2579-8.

PMID: 30442143Free PMC ArticleSimilar articlesSelect item 2332661193.

03/06/2019
(Collected by Dr. Huynh Hong Quang)  

Announcement

LIBRARY
Book
Magazine
Document
Photos
Thesis
Documentary form
Research studies
PROFFESSIONAL SOFTWARE
Malaria forecast & management
Document management
Personel management
LEGAL DOCUMENTS
Law
Decision
Decree
Instruction
Circular
Official document
Reports
Others
SPECIFIED IMFORMATION
Malaria facts
Malaria epidemic
Petechial fever
HEALTH SERVICES
Hospital & medical centre
Drugstore
Surgery
Your doctor

Institue of Malariology Parastology and Entomology Quy Nhon
Address: 611B Nguyen Thai Hoc Str,. Quy Nhon City
Tel: (84) 056 846571 Fax: (84) 056 846755
• Designed by Quang Ich JSC